Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-gamma assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, You Sun | - |
dc.contributor.author | Kim, Young-Ho | - |
dc.contributor.author | Kim, Won Ho | - |
dc.contributor.author | Kim, Joo Sung | - |
dc.contributor.author | Park, Young Sook | - |
dc.contributor.author | Yang, Suk-Kyun | - |
dc.contributor.author | Ye, Byong Duk | - |
dc.contributor.author | Jang, Byung Ik | - |
dc.contributor.author | Jung, Sung-Ae | - |
dc.contributor.author | Jeen, Yoon Tae | - |
dc.contributor.author | Cheon, Jae Hee | - |
dc.contributor.author | Choi, Yong Sung | - |
dc.contributor.author | Choi, Jai Hyun | - |
dc.contributor.author | Kim, Beom Jin | - |
dc.contributor.author | Choi, Chang Hwan | - |
dc.contributor.author | Han, Dong Soo | - |
dc.date.available | 2020-11-03T01:50:25Z | - |
dc.date.issued | 2011-08-17 | - |
dc.identifier.issn | 0009-8981 | - |
dc.identifier.issn | 1873-3492 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/13243 | - |
dc.description.abstract | Background: Differential diagnosis of Crohn's disease (CD) from intestinal tuberculosis (ITB) is challenging. Anti-Saccharomyces cerevisiae antibody (ASCA) is a specific serological marker for CD and INF-gamma assay (QuantiFERON-TB gold test, QFT) is a good supplementary diagnostic tool for ITB. We evaluated the clinical usefulness of ASCA and QFT for differential diagnosis of CD from ITB in Korean adults. Methods: A total of 147 patients suspected to have ITB or CD were prospectively enrolled from 13 hospitals. ASCA IgG and IgA serum titers were measured by ELISA, and the QFT test was also performed. Results: Thirty-two of 72 (44.4%) patients with CD were ASCA positive (titer >25 U) compared to 10 of 75 ITB patients (13.3%) and 3 of 20 healthy controls (15%) (p<0.01). The QFT test was positive in 7 patients with CD (9.7%) and 50 patients with ITB (66.6%) (p<0.01). In cases which ASCA positive/QFT negative, the sensitivity, specificity, positive predictive value, and negative predictive value for the diagnosis of CD were 44.4%, 96.0%, 91.4%, and 64.3%, respectively. Conclusion: ASCA is a useful diagnostic tool for CD in Korea, where ITB is prevalent. In particular, when ASCA is combined with QFT, effective differential diagnosis of CD from ITB is possible. 2011 Elsevier B.V. All rights reserved. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.title | Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-gamma assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1016/j.cca.2011.04.029 | - |
dc.identifier.scopusid | 2-s2.0-79959295334 | - |
dc.identifier.wosid | 000292997100005 | - |
dc.identifier.bibliographicCitation | CLINICA CHIMICA ACTA, v.412, no.17-18, pp 1527 - 1532 | - |
dc.citation.title | CLINICA CHIMICA ACTA | - |
dc.citation.volume | 412 | - |
dc.citation.number | 17-18 | - |
dc.citation.startPage | 1527 | - |
dc.citation.endPage | 1532 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Medical Laboratory Technology | - |
dc.relation.journalWebOfScienceCategory | Medical Laboratory Technology | - |
dc.subject.keywordPlus | INFLAMMATORY-BOWEL-DISEASE | - |
dc.subject.keywordPlus | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | - |
dc.subject.keywordPlus | EPIDEMIOLOGY | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | DISTRICT | - |
dc.subject.keywordPlus | BIOPSIES | - |
dc.subject.keywordPlus | BAKERS | - |
dc.subject.keywordPlus | YEAST | - |
dc.subject.keywordPlus | INDIA | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | Anti-Saccharomyces cerevisiae antibody | - |
dc.subject.keywordAuthor | Crohn's disease | - |
dc.subject.keywordAuthor | Intestinal tuberculosis | - |
dc.subject.keywordAuthor | INF-gamma assay | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.